Recent studies have shown that KDM7C regulates interleukin 4 production in CD4+ T cells and may play a role in the development of immune diseases [61] and that it directly destabilises SREBP1c and reduces SREBP1c‐dependent lipogenesis [62]. This evidence concerns the gene PHF2 and immune system disorder.